2-[18F]-Fluoro-2-deoxy-d-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx
- 31 August 2007
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 33 (6) , 790-795
- https://doi.org/10.1016/j.ejso.2007.01.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-Term Results of a Multimodal Intensification Regimen for Previously Untreated Advanced Resectable Squamous Cell Cancer of the Oral Cavity, Oropharynx, or HypopharynxThe Laryngoscope, 2006
- Single-Cycle Induction Chemotherapy Selects Patients With Advanced Laryngeal Cancer for Combined Chemoradiation: A New Treatment ParadigmJournal of Clinical Oncology, 2006
- Positron-Emission Tomography for Surveillance of Head and Neck CancerThe Laryngoscope, 2005
- 2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinomaCancer, 2004
- Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal CancerNew England Journal of Medicine, 2003
- Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynxCancer, 2002
- Standardized Uptake Value of 2-[18F] Fluoro-2-Deoxy-D-Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without ChemotherapyJournal of Clinical Oncology, 2002
- Overview of Combined Modality Therapies for Head and Neck CancerJNCI Journal of the National Cancer Institute, 1993
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991
- Prediction of survival in glioma patients by means of positron emission tomographyJournal of Neurosurgery, 1985